DBSP
Roster  DBSP Departments VA-MD Vet Med

DBSP Faculty

Paul Christopher Roberts

Paul Christopher Roberts, Ph.D.

Associate Professor
Virology
Department of Biomedical Sciences & Pathobiology
 
e-mail: robec06@vt.edu
Capsule Biography (PDF)

 

Education

1992-1996 Postdoctoral, Microbiology/Virology
Emory University
Atlanta, GA
1992 Ph.D., Microbiology/Virology
Philipps-Universität Marburg
Marburg, Germany
1988 M.S., Microbiology
Philipps-Universität Marburg
Marburg, Germany
1984 B.S., Biology
Davidson College
Davidson, NC

Research Interests

For research project details, please see Dr. Roberts' laboratory research flyer.

  • Viral Vaccine Development
  • Host Pathogen Interactions and Viral:Bacterial Synergy in Disease Exacerbation
  • Immunotherapy and Virotherapy targeting Ovarian Cancer
     

Professional Experience

2007-present Associate Professor, Virology
Department of Biomedical Sciences and Pathobiology
Virginia-Maryland Regional College of Veterinary Medicine
Virginia Tech
Blacksburg, VA
1999-2007 Assistant Professor
Department of Immunology and Microbiology
Wayne State University School of Medicine
Detroit, MI
1996–1999 Senior Research Associate
Emory University School of Medicine
Atlanta, GA
1992-1996 Research Associate
Emory University School of Medicine
Atlanta, GA

Selected Honors & Awards

2006-Present Member, NIH Study Section ZRG1 IDM-10 “Bugs and Drugs”
2006 Member, DOD OC-1 Study Section, May
2005-2006 Member, NIH Study Section ZRG1 IDM-B
2003 Member, NIH Study Section VR-3, July
2006 Wayne State University, School of Medicine Teaching Award
2002 Wayne State University, School of Medicine Teaching Award

Professional Memberships

  • American Society of Virology
  • American Association of Cancer Research
  • American Society of Microbiology
     

Selected Publications

  1. Andrew Herbert, Nicole Doyon-Reale, Roy S. Sundick and Paul C. Roberts. (2008). Membrane-bound Cytokines Augment Influenza Virus Vaccines and Protect Against Lethal Challenge in Mice. (submitted to J. Interferon and Cytokine Research)
  2. Amouzegar, T. K. Trivedi, P.P, N.A. Wolf, P.C. Roberts, R. H. Swanborg. (2008). A Unique Subset of Bone Marrow-Derived Natural Killer Cells Regulates T Cell Activation. (J. Leukocyte Biology; in press)
  3. Yufang Yang, David Legget, Andrew Herbert, Roy S. Sundick and Paul C. Roberts. (2008). A novel method to incorporate cytokines as adjuvants on the surface of whole, virus vaccines. (submitted to J. Interferon and Cytokine Research)
  4. Janice Speshock, N. Doyon-Reale, R. Rabah, M. Neely and P.C. Roberts. (2007). Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae (serotype 3). Infection and Immunity 75 (6) 3102-3111.
  5. Prachi P. Trivedi, Taba K. Amouzegar, Paul C. Roberts, Norbert A. Wolf, and Robert H. Swanborg. (2006). Regulation of Adaptive Immunity by cells of the the innate immune system: Bone marrow natural killer cells inhibit T cell proliferation. "Crossroads between Innate and Adaptive Immunity", Proceedings of the Aegean Conference, in Advances in Experimental Medicine and Biology, Springer Verlag.
  6. Aviva Levine Fridman, L. Tang, O. I. Kulaeva, B. Y., Q. Li, P. C. Roberts, J. Abrams, M. A. Tainsky. (2006). Expression Profiling Identifies Three Pathways Altered in Cellular Immortalization: Interferon, Cell Cycle and Cytoskeleton., J Gerontol A Biol Sci Med Sci, 61 (9) 879-89.
  7. Lin Tang, Paul C. Roberts, Janice M. Kraniak, Qunfang Li, , and Michael A. Tainsky. (2006). STAT1 expression is not sufficient to regulate interferon-signaling pathway in cellular immortalization. J Interferon and Cytokine Res. 26 (1) 14-26.
  8. Roberts, P.C., Mottillo, E.P., Baxa, A., Reale, N., Gregoire, L., Rabah, R., Lancaster, W.D., and Schmelz, E.M. (2005) Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model. Neoplasia 7 (10) 944-956.
  9. Prachi P. Trivedi, Paul C. Roberts, Norbert A. Wolf, and Robert H. Swanborg. (2005). NK Cells Inhibit T Cell Proliferation via p21-Mediated Cell Cycle Arrest. J. Immunol. Volume 174 / No. 8/April 15th.